MetLife Investment Management, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 158 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,470,204
-22.5%
46,4960.0%0.01%
-14.3%
Q2 2023$1,896,107
+15.5%
46,496
+5.6%
0.01%
+16.7%
Q1 2023$1,641,035
+6.8%
44,0310.0%0.01%0.0%
Q4 2022$1,536,242
-31.5%
44,031
+9.8%
0.01%
-36.8%
Q3 2022$2,244,052
+10.6%
40,101
+2.3%
0.02%
+11.8%
Q2 2022$2,028,164
-25.3%
39,184
+4.9%
0.02%
-5.6%
Q1 2022$2,715,097
-4.9%
37,362
+54.7%
0.02%
-25.0%
Q4 2021$2,855,851
-11.9%
24,1530.0%0.02%
-20.0%
Q3 2021$3,240,125
-12.2%
24,153
+6.0%
0.03%
-14.3%
Q2 2021$3,688,957
+130.5%
22,784
+14.2%
0.04%
+133.3%
Q1 2021$1,600,525
+47.5%
19,9430.0%0.02%
+36.4%
Q4 2020$1,084,899
+173.6%
19,9430.0%0.01%
+175.0%
Q3 2020$396,467
-5.4%
19,9430.0%0.00%
-20.0%
Q2 2020$419,202
+117.8%
19,943
+26.7%
0.01%
+66.7%
Q1 2020$192,512
-16.6%
15,7410.0%0.00%
+50.0%
Q4 2019$230,920
+9.9%
15,7410.0%0.00%0.0%
Q3 2019$210,142
-18.4%
15,7410.0%0.00%
-33.3%
Q2 2019$257,680
-4.2%
15,7410.0%0.00%0.0%
Q1 2019$268,856
+25.1%
15,7410.0%0.00%0.0%
Q4 2018$214,865
-52.3%
15,7410.0%0.00%
-40.0%
Q3 2018$450,507
+4.5%
15,7410.0%0.01%0.0%
Q2 2018$431,000
+169.4%
15,741
+107.2%
0.01%
+150.0%
Q1 2018$160,000
+9.6%
7,5970.0%0.00%0.0%
Q4 2017$146,0007,5970.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 744,160$54,078,0005.79%
Discovery Value Fund 986,173$71,665,0005.28%
Ally Bridge Group (NY) LLC 60,000$4,360,0003.23%
MPM BioImpact LLC 159,409$11,584,0003.11%
ARK Investment Management 8,981,029$652,651,0002.72%
Elmwood Wealth Management, Inc. 67,599$4,912,0002.52%
Nikko Asset Management Americas, Inc. 2,872,269$192,442,0001.41%
Frazier Life Sciences Management, L.P. 203,684$14,802,0001.26%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$8,098,0001.22%
Merlin Capital, Inc 11,575$841,0001.11%
View complete list of INTELLIA THERAPEUTICS INC shareholders